{"filing": {"accession": "0001493152-26-033203", "cik": "0001011060", "ticker": "NORD", "company_name": "Nordicus Partners Corp", "form_type": "10-K", "filing_type": "10-K", "filing_date": "2026-07-14", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315226033203/0001493152-26-033203-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315226033203/0001493152-26-033203-index.htm", "period_of_report": "2026-03-31"}, "html_url": "/api/filings/000149315226033203/stream", "exhibits": [{"exhibit_number": "3.1", "exhibit_type": "3", "description": "", "filename": "ex3-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315223043857/ex3-1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "", "filename": "ex3-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315223018489/ex3-1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.3", "exhibit_type": "3", "description": "", "filename": "ex3-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315223043857/ex3-2.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "10.1", "exhibit_type": "10", "description": "", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315221025667/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.2", "exhibit_type": "10", "description": "", "filename": "ex10-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315221025667/ex10-2.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.3", "exhibit_type": "10", "description": "", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315222009732/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.4", "exhibit_type": "10", "description": "", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315222028536/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.5", "exhibit_type": "10", "description": "", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315222033965/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.6", "exhibit_type": "10", "description": "", "filename": "ex10-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315222033965/ex10-2.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.7", "exhibit_type": "10", "description": "", "filename": "ex10-11.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315223043857/ex10-11.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.8", "exhibit_type": "10", "description": "", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000149315223021799/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.9", "exhibit_type": "10", "description": "", "filename": "asnb8k_ex10z37.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1011060/000101106017000026/asnb8k_ex10z37.htm", "category": "contracts", "incorporated_by_reference": true}], "sections": [{"section_name": "part_1", "section_title": "Part I", "start_position": 4071, "end_position": 4081}, {"section_name": "item_1", "section_title": "Business", "start_position": 4081, "end_position": 4102}, {"section_name": "item_1a", "section_title": "Risk Factors", "start_position": 4102, "end_position": 4128}, {"section_name": "item_1b", "section_title": "Unresolved Staff Comments", "start_position": 4128, "end_position": 4167}, {"section_name": "item_1c", "section_title": "Cybersecurity", "start_position": 4167, "end_position": 4194}, {"section_name": "item_2", "section_title": "Properties", "start_position": 4194, "end_position": 4217}, {"section_name": "item_3", "section_title": "Legal Proceedings", "start_position": 4217, "end_position": 4247}, {"section_name": "item_4", "section_title": "Mine Safety Disclosures", "start_position": 4247, "end_position": 4283}, {"section_name": "part_2", "section_title": "Part II", "start_position": 4283, "end_position": 4451}, {"section_name": "item_7", "section_title": "Management's Discussion and Analysis", "start_position": 4451, "end_position": 4550}, {"section_name": "item_7a", "section_title": "Quantitative and Qualitative Disclosures", "start_position": 4550, "end_position": 4624}, {"section_name": "item_8", "section_title": "Financial Statements", "start_position": 4624, "end_position": 4779}, {"section_name": "item_9a", "section_title": "Controls and Procedures", "start_position": 4779, "end_position": 4817}, {"section_name": "item_9b", "section_title": "Other Information", "start_position": 4817, "end_position": 4849}, {"section_name": "part_3", "section_title": "Part III", "start_position": 4849, "end_position": 4861}, {"section_name": "item_10", "section_title": "Directors and Executive Officers", "start_position": 4861, "end_position": 4930}, {"section_name": "item_11", "section_title": "Executive Compensation", "start_position": 4930, "end_position": 4967}, {"section_name": "item_12", "section_title": "Security Ownership", "start_position": 4967, "end_position": 5076}, {"section_name": "item_13", "section_title": "Certain Relationships", "start_position": 5076, "end_position": 5217}, {"section_name": "part_4", "section_title": "Part IV", "start_position": 5217, "end_position": 5229}, {"section_name": "item_15", "section_title": "Exhibits and Financial Statement Schedules", "start_position": 5229, "end_position": 5283}, {"section_name": "item_16", "section_title": "Form 10-K Summary", "start_position": 5283, "end_position": 20658}, {"section_name": "item_5", "section_title": "Market for Registrant's Common Equity", "start_position": 20658, "end_position": 185796}, {"section_name": "item_14", "section_title": "Principal Accountant Fees", "start_position": 185796, "end_position": 192236}], "tables": [{"table_index": 2, "table_type": "text", "caption": null, "header_text": "Delaware04-3186647"}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": "280\n South Beverly Dr.,Suite 505,Beverly Hills,CA90212"}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": "NoneNone"}, {"table_index": 5, "table_type": "text", "caption": null, "header_text": "\u2610\n Large Accelerated Filer\u2610\n Accelerated Filer"}, {"table_index": 7, "table_type": "exhibit_index", "caption": null, "header_text": "Page"}, {"table_index": 11, "table_type": "text", "caption": null, "header_text": "\u2013Scout\n and Accelerate: Nordicus targets high-impact potential companies, providing capital, resources\n and expertise to drive critical milestones such as patent filings and clinical trials."}, {"table_index": 12, "table_type": "text", "caption": null, "header_text": "1.Sale\n or merger of the portfolio company."}, {"table_index": 18, "table_type": "text", "caption": null, "header_text": "Plan CategoryNumber ofsecurities to beissued uponexercise ofoutstandingoptions, warrantsand rightsWeightedaverageexercise price ofoutstandingoptions,warrants andrightsNumber ofsecuritiesremainingavail"}, {"table_index": 31, "table_type": "financial", "caption": null, "header_text": "Level\n 1:Quoted\n market prices available in active markets for identical assets or liabilities as of the reporting date."}, {"table_index": 34, "table_type": "financial", "caption": null, "header_text": "Report of Independent Registered Public Accounting Firm(PCAOB ID5525)F-1"}, {"table_index": 36, "table_type": "financial", "caption": null, "header_text": "\u25cfWe\n obtained and reviewed the Company\u2019s valuation specialist\u2019s reports supporting\n the annual goodwill impairment analysis."}, {"table_index": 38, "table_type": "financial", "caption": null, "header_text": "March 31, 2026March 31, 2025"}, {"table_index": 40, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 42, "table_type": "financial", "caption": null, "header_text": "SharesAmountSharesAmountSharesAmountCapitalDeficitStockIncome (Loss)to ParentInterestEquity"}, {"table_index": 44, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 57, "table_type": "financial", "caption": null, "header_text": "Level\n 1:Quoted\n market prices available in active markets for identical assets or liabilities as of the reporting date."}, {"table_index": 60, "table_type": "financial", "caption": null, "header_text": "\u25cfIdentification\n of a contract with a customer;"}, {"table_index": 62, "table_type": "text", "caption": null, "header_text": "OrocidinBio-ConvertTotal"}, {"table_index": 66, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 67, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 70, "table_type": "text", "caption": null, "header_text": "Number\n ofStock OptionsWeighted-averageExercise Priceper Option*Weighted-averageRemainingContractual Term(Years)AggregateIntrinsicValue"}, {"table_index": 72, "table_type": "text", "caption": null, "header_text": "Expected volatility92%"}, {"table_index": 74, "table_type": "text", "caption": null, "header_text": "Exercise priceVariable"}, {"table_index": 76, "table_type": "text", "caption": null, "header_text": "OrocidinBio-ConvertTotal"}, {"table_index": 77, "table_type": "text", "caption": null, "header_text": "OrocidinBio-ConvertTotal"}, {"table_index": 78, "table_type": "text", "caption": null, "header_text": "Weighted"}, {"table_index": 80, "table_type": "financial", "caption": null, "header_text": "March\n 31, 2026March\n 31, 2025"}, {"table_index": 81, "table_type": "financial", "caption": null, "header_text": "March\n 31, 2026"}, {"table_index": 82, "table_type": "text", "caption": null, "header_text": "March\n 31, 2025"}, {"table_index": 84, "table_type": "financial", "caption": null, "header_text": "March\n 31, 2026March\n 31, 2025"}, {"table_index": 88, "table_type": "text", "caption": null, "header_text": "NameAgePosition"}, {"table_index": 89, "table_type": "text", "caption": null, "header_text": "(1)Resigned\n from the Board on June 3, 2024."}, {"table_index": 92, "table_type": "text", "caption": null, "header_text": "Named Executive\n OfficerFiscalYearSalary($)Bonus($)OptionAwards($)(1)All\n OtherCompensation($)Total($)"}, {"table_index": 95, "table_type": "text", "caption": null, "header_text": "Option\n Awards"}, {"table_index": 99, "table_type": "text", "caption": null, "header_text": "Name and Address of Beneficial OwnerAmount andNature ofBeneficialOwnershipPercentage ofClass (1)"}, {"table_index": 100, "table_type": "text", "caption": null, "header_text": "(1)Based\n on 19,798,896 shares of common stock as of June 18, 2026, composed of 19,173,896 outstanding shares of our common stock, 550,000\n shares of our common stock underlying outstanding incentive "}, {"table_index": 103, "table_type": "text", "caption": null, "header_text": "March\n 31, 2026March\n 31, 2025"}, {"table_index": 105, "table_type": "exhibit_index", "caption": null, "header_text": "ExhibitFiled\n or Furnished"}, {"table_index": 107, "table_type": "exhibit_index", "caption": null, "header_text": "10.1Second\n Amended and Restated Employment Agreement, dated as of April 1, 2024, between EKIMAS Corporation and Henrik Rouf10-K10.17/13/2024"}, {"table_index": 110, "table_type": "text", "caption": null, "header_text": "By/s/\n Henrik Rouf"}], "exhibits_pending": true, "cdn_html": true, "response_time_ms": 24}